HeartBeam Inc. (BEAT)
| Bid | 1.9 |
| Market Cap | 65.76M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.62M |
| EPS (ttm) | -0.73 |
| PE Ratio (ttm) | -2.67 |
| Forward PE | -4 |
| Analyst | Hold |
| Ask | 2.1 |
| Volume | 52,734 |
| Avg. Volume (20D) | 101,789 |
| Open | 1.91 |
| Previous Close | 1.98 |
| Day's Range | 1.92 - 2.04 |
| 52-Week Range | 1.70 - 3.48 |
| Beta | -0.66 |
About BEAT
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the...
Analyst Forecast
According to 1 analyst ratings, the average rating for BEAT stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 310.26% from the latest price.
Stock Forecasts
4 weeks ago · businesswire.com
HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common StockSANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock.
